Anaphylaxis EBM: Dr. Brissett

  1. Describe the epidemiology and risk factors for biphasic reactions in anaphylaxis.
  2. Evaluate recent evidence for observation time after epinephrine administration.
  3. Discuss the role of adjunctive therapies in anaphylaxis
Session date: 
11/20/2025 - 9:00am to 12:00pm EST
Add to calendar: 
  • 2.00 AMA PRA Category 1 Credit™
    Children’s National Hospital designates this Live activity for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 2.00 Participation
    Successful completion of this continuing education activity.
Please login or register to take this course.
Faculty List: 
Speaker(s)

Kammeron Brissett, MD

has no relevant financial relationships to disclose at this time.